Compugen (CGEN) Misses Q2 EPS by 2c

Compugen (NASDAQ: CGEN) reported Q2 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.26 million versus the consensus estimate of $3.31 million.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Barclays Upgrades 1&1 AG (1U1:GR) to Overweight
• Lonza Group (LONN:SW) (LZAGY) PT Raised to CHF720 at RBC Capital
• CLSA Upgrades a2 Milk Co (A2M:AU) (ACOPF) to Hold (3)